Sentence examples for progress of cure from inspiring English sources

Additionally, the transformation mechanism of the intermolecular and intramolecular hydrogen bonding during the progress of cure is proposed for the first time.

The cure data of several mixes and the kinetic as well as mechanical properties of the corresponding vulcanizates are recorded in Table 3 and the progress of cure is depicted in the rheograph (Fig. 1a c).

However, the FTIR curve fitting results show that both the chain length and bulkiness of alkyl group have an effect on the hydrogen bonding network of the polybenzoxazines, and facilitate the formation of intermolecular hydrogen bonding during the progress of cure.

The progress of the curing was investigated isothermally (80 °C, 90 °C, 100 °C, and 110 °C) for 120 min for three resins with different degrees of condensation.

Similarly, a high percentage of Asian patients wanted to know the specific name of the illness (93.8%), week-by-week progress (86.4%), the chance of cure (84.0%), all possible treatment (87.7%) and all possible side effects (85.2%).

Three applications were presented: (1) monitoring of the cure progress of the bonded repair adhesive, (2) identification of the initial artificial debonding between the composite patch and the metal structure, and (3) monitoring of the damage repaired by a bonded patch, which is under fatigue cycles.

In this attempt, Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and dynamic mechanical thermal analysis (DMTA) were used to monitor the cure progress of 977-2A epoxy resin and carbon fiber reinforced composite.

By considerably changing the landscape of drug development for children, the law will provide an opportunity to make further progress in the cure and quality of cure of children with cancer, at a time when truly innovative and effective anticancer drugs are becoming available.

One of the major factors that govern the progress of polymerization is the curing temperature.

Antiviral therapies consisting of HBV polymerase inhibitors and/or interferon have been used in active chronic HBV carriers, 1 which may delay the progress of HBV‐related diseases, but cannot cure HBV due to the persistence of HBV covalently closed circular DNA (cccDNA) in hepatocytes.

Patients frustrated by what they saw as the slow progress of science and desperate for a cure began paying for access to unproven interventions despite strong discouragement from scientists and doctors [ 3, 6– 9].